EcoDrugPlus

Retinoic Acid Receptor Beta

Ensembl ID : ENSNFUG00015014142
Gene Symbol: RARB
1 Cross references
384 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSNFUG00015017410
Gene Symbol: RARG
3 Cross references
353 Possible Orthologues:

Retinoic Acid Receptor Gamma-A-Like

Ensembl ID : ENSNFUG00015023002
Gene Symbol: LOC107385640
3 Cross references
377 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSNFUG00015018214
Gene Symbol: RXRA
3 Cross references
225 Possible Orthologues:

Ribosomal Protein L10

Ensembl ID : ENSNFUG00015008333
Gene Symbol: RPL10
3 Cross references
407 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSNFUG00015023812
Gene Symbol: RPL10A
3 Cross references
366 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSNFUG00015021595
Gene Symbol: RPL11
3 Cross references
288 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSNFUG00015003124
Gene Symbol: RPL12
3 Cross references
478 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSNFUG00015019590
Gene Symbol: RPL13
3 Cross references
275 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSNFUG00015008460
Gene Symbol: RPL13A
3 Cross references
368 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSNFUG00015020642
Gene Symbol: RPL14
3 Cross references
309 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSNFUG00015014462
Gene Symbol: RPL15
3 Cross references
357 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).